ASTEC LIFESCIENCES LTD.
Quaterly Results
Particulars | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 |
---|---|---|---|---|
Audited / UnAudited | UnAudited | UnAudited | UnAudited | Audited |
Net Sales | 507.94 | 1107.89 | 1428.49 | 1269.72 |
Total Expenditure | 691.26 | 1142.12 | 1397.16 | 1215.72 |
PBIDT (Excl OI) | -183.32 | -34.22 | 31.32 | 54 |
Other Income | 9.09 | 9.79 | 17.09 | 25.75 |
Operating Profit | -174.22 | -24.43 | 48.40 | 79.75 |
Interest | 60.95 | 59.94 | 64.62 | 63.99 |
Exceptional Items | NA | NA | NA | NA |
PBDT | -235.17 | -84.37 | -16.21 | 15.76 |
Depreciation | 87.03 | 91.58 | 93.86 | 77.6 |
Profit Before Tax | -322.2 | -175.96 | -110.07 | -61.83 |
Tax | -78.93 | -41.81 | -28.21 | -12.09 |
Provisions and contingencies | NA | NA | NA | NA |
Profit After Tax | -243.27 | -134.15 | -81.86 | -49.74 |
Extraordinary Items | NA | NA | NA | NA |
Prior Period Expenses | NA | NA | NA | NA |
Other Adjustments | NA | NA | NA | NA |
Net Profit | -243.27 | -134.15 | -81.86 | -49.74 |
Minority Interest | -0.08 | -0.12 | -0.09 | -0.08 |
Shares of Associates | ||||
Other related items | ||||
Misc. Expenses Written off | NA | NA | NA | NA |
Consolidated Net Profit | -243.34 | -134.27 | -81.95 | -49.83 |
Equity Capital | 196.09 | 196.09 | 196.06 | 196.06 |
Face Value (IN RS) | 10 | 10 | 10 | 10 |
Reserves | NA | NA | NA | NA |
Calculated EPS | -12.40 | -6.84 | -4.17 | -2.54 |
Calculated EPS (Annualised) | -49.63 | -27.38 | -16.71 | -10.16 |
No of Public Share Holdings | 6519350 | 6519350 | 6516245 | 6515804 |
% of Public Share Holdings | 33.25 | 33.25 | 33.24 | 33.23 |
| NA | NA | NA | NA |
PBIDTM% (Excl OI) | -36.09 | -3.08 | 2.19 | 4.25 |
PBIDTM% | -34.29 | -2.20 | 3.38 | 6.28 |
PBDTM% | -46.29 | -7.61 | -1.13 | 1.24 |
PBTM% | -63.43 | -15.88 | -7.70 | -4.87 |
PATM% | -47.89 | -12.10 | -5.73 | -3.91 |
"; | Notes | Notes | Notes | Notes |